Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways

Baiying Qingmai Formulation (BF) is a classical clinical prescription used for decades to treat thromboangiitis obliterans (TAO). Although it effectively relieves pain and ischemic ulcers in patients with TAO, its anti-TAO mechanisms remain unclear. The chemical components of BF were analyzed using...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Chongchong, Liu, Li, Huang, Chuanqi, Hu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592700/
https://www.ncbi.nlm.nih.gov/pubmed/36304158
http://dx.doi.org/10.3389/fphar.2022.1018438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592700/
https://www.ncbi.nlm.nih.gov/pubmed/36304158
http://dx.doi.org/10.3389/fphar.2022.1018438

Ejemplares similares